These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7329 related articles for article (PubMed ID: 19514381)

  • 21. HLA-G expression is induced in Epstein-Barr virus-transformed B-cell lines by culture conditions.
    Gazit E; Sherf M; Balbin E; Muratov A; Goldstein I; Loewenthal R
    Hum Immunol; 2007 Jun; 68(6):463-8. PubMed ID: 17509445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
    Ohnmacht GA; Marincola FM
    J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
    Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
    J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
    Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
    Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients.
    Jackson AM; Connolly JE; Matsumoto S; Noguchi H; Onaca N; Levy MF; Naziruddin B
    Transplantation; 2009 Feb; 87(4):500-6. PubMed ID: 19307785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
    Sangrouber D; Marcou C; Le Discorde M; Chang CC; Carosella ED; Moreau P
    J Immunol Methods; 2007 Sep; 326(1-2):54-62. PubMed ID: 17689555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
    Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
    Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?
    Yue FY; Geertsen R; Hemmi S; Burg G; Pavlovic J; Laine E; Dummer R
    Eur J Immunol; 1999 Jun; 29(6):1762-73. PubMed ID: 10382738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution analysis of HLA class I alterations in colorectal cancer.
    Dierssen JW; de Miranda NF; Mulder A; van Puijenbroek M; Verduyn W; Claas FH; van de Velde CJ; Jan Fleuren G; Cornelisse CJ; Corver WE; Morreau H
    BMC Cancer; 2006 Oct; 6():233. PubMed ID: 17014712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
    Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
    Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of autologous tumor-specific cytotoxic T-cells using HLA-A region matched allogeneic melanoma.
    Crowley NJ; Darrow TL; Seigler HF
    Curr Surg; 1989; 46(5):393-6. PubMed ID: 2805780
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA-G in the skin--friend or foe?
    Urosevic M
    Semin Cancer Biol; 2007 Dec; 17(6):480-4. PubMed ID: 17981049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of human melanoma antigen expression by IFN-beta.
    Dunn IS; Haggerty TJ; Kono M; Durda PJ; Butera D; Macdonald DB; Benson EM; Rose LB; Kurnick JT
    J Immunol; 2007 Aug; 179(4):2134-42. PubMed ID: 17675472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human decidual stromal cells express HLA-G: Effects of cytokines and decidualization.
    Blanco O; Tirado I; Muñoz-Fernández R; Abadía-Molina AC; García-Pacheco JM; Peña J; Olivares EG
    Hum Reprod; 2008 Jan; 23(1):144-52. PubMed ID: 17951263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment and immune escape.
    Ferrone S; Whiteside TL
    Surg Oncol Clin N Am; 2007 Oct; 16(4):755-74, viii. PubMed ID: 18022543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
    Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
    J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 367.